• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRCA1 的克隆“竞赛”。

"The race" to clone BRCA1.

机构信息

Department of Medicine and Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.

出版信息

Science. 2014 Mar 28;343(6178):1462-5. doi: 10.1126/science.1251900.

DOI:10.1126/science.1251900
PMID:24675952
Abstract

The existence of BRCA1 was proven in 1990 by mapping predisposition to young-onset breast cancer in families to chromosome 17q21. Knowing that such a gene existed and approximately where it lay triggered efforts by public and private groups to clone and sequence it. The press baptized the competition "the race" and reported on it in detail for the next 4 years. BRCA1 was positionally cloned in September 1994. Twenty years later, I reflect on "the race" and its consequences for breast cancer prevention and treatment.

摘要

BRCA1 的存在于 1990 年通过将家族中早发性乳腺癌的易感性映射到染色体 17q21 而得到证实。知道这样的基因存在,并且大致位于何处,这促使公共和私人团体努力对其进行克隆和测序。媒体将这场竞争命名为“竞赛”,并在接下来的 4 年里对此进行了详细报道。BRCA1 于 1994 年在定位上被克隆。20 年后,我反思了“竞赛”及其对乳腺癌预防和治疗的影响。

相似文献

1
"The race" to clone BRCA1.BRCA1 的克隆“竞赛”。
Science. 2014 Mar 28;343(6178):1462-5. doi: 10.1126/science.1251900.
2
Linkage analysis of BRCA1 in Japanese breast cancer families.日本乳腺癌家族中BRCA1的连锁分析。
Jpn J Cancer Res. 1994 Dec;85(12):1233-9. doi: 10.1111/j.1349-7006.1994.tb02935.x.
3
Physical mapping, cloning, and identification of genes within a 500-kb region containing BRCA1.对包含BRCA1的500千碱基区域内的基因进行物理图谱绘制、克隆和鉴定。
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4362-6. doi: 10.1073/pnas.92.10.4362.
4
Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.早发性乳腺癌和卵巢癌家族中肿瘤的种系BRCA1突变及野生型等位基因缺失
Clin Cancer Res. 1995 May;1(5):539-44.
5
BRCA1 and BRCA2 in breast cancer.乳腺癌中的BRCA1和BRCA2
Breast Cancer Res Treat. 1999 Mar;54(1):1-10. doi: 10.1023/a:1006189906896.
6
Genetic mapping of the BRCA1 region on chromosome 17q21.17号染色体q21区域BRCA1基因座的基因定位
Am J Hum Genet. 1994 Mar;54(3):516-25.
7
22 genes from chromosome 17q21: cloning, sequencing, and characterization of mutations in breast cancer families and tumors.来自17号染色体q21区域的22个基因:乳腺癌家族和肿瘤中突变的克隆、测序及特征分析
Genomics. 1995 Jan 1;25(1):256-63. doi: 10.1016/0888-7543(95)80133-7.
8
CGH analysis of familial non-BRCA1/BRCA2 breast tumors and mutation screening of a candidate locus on chromosome 17q11.2-12.家族性非BRCA1/BRCA2乳腺癌肿瘤的比较基因组杂交分析及17q11.2 - 12染色体上候选基因座的突变筛查
Int J Mol Med. 2005 Jul;16(1):135-41.
9
No mutations in the BACH1 gene in BRCA1 and BRCA2 negative breast-cancer families linked to 17q22.与17q22相关的BRCA1和BRCA2阴性乳腺癌家族中,BACH1基因无突变。
Int J Cancer. 2002 Apr 1;98(4):638-9. doi: 10.1002/ijc.10214.
10
A YAC-, P1-, and cosmid-based physical map of the BRCA1 region on chromosome 17q21.基于酵母人工染色体(YAC)、P1噬菌体和黏粒的17号染色体q21区域BRCA1基因座物理图谱。
Genomics. 1995 Jan 1;25(1):264-73. doi: 10.1016/0888-7543(95)80134-8.

引用本文的文献

1
Enhancing clinical research with pharmacogenomics: a practical perspective.从实践角度看,利用药物基因组学加强临床研究。
Bioanalysis. 2025 Mar;17(6):399-411. doi: 10.1080/17576180.2025.2481019. Epub 2025 Mar 21.
2
Editorial: Exploring genomic instability of cancers: applications in diagnosis and treatment.社论:探索癌症的基因组不稳定性:在诊断和治疗中的应用
Front Cell Dev Biol. 2025 Feb 7;13:1528281. doi: 10.3389/fcell.2025.1528281. eCollection 2025.
3
Mutations and High Prevalence of dMMR-associated Mutational Signatures as Prognostic Indicators in Metastatic Colorectal Cancer.
错配修复缺陷(dMMR)相关突变特征的突变与高发生率作为转移性结直肠癌的预后指标
J Cancer. 2024 Apr 8;15(10):3140-3150. doi: 10.7150/jca.94410. eCollection 2024.
4
BRCA Mutations and Fertility Preservation.BRCA 基因突变与生育力保存。
Int J Mol Sci. 2023 Dec 22;25(1):204. doi: 10.3390/ijms25010204.
5
Oncogenic Impact of TONSL, a Homologous Recombination Repair Protein at the Replication Fork, in Cancer Stem Cells.TONSL,复制叉处同源重组修复蛋白,在癌症干细胞中的致癌作用。
Int J Mol Sci. 2023 May 31;24(11):9530. doi: 10.3390/ijms24119530.
6
Targeting the / deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights.用聚(ADP-核糖)聚合酶(PARP)抑制剂靶向缺陷型癌症:临床结果与机制洞察
Front Cell Dev Biol. 2023 Mar 22;11:1133472. doi: 10.3389/fcell.2023.1133472. eCollection 2023.
7
Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches.卵巢癌中的同源重组缺陷:从生物学原理到当前的诊断方法
J Pers Med. 2023 Feb 2;13(2):284. doi: 10.3390/jpm13020284.
8
Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations.乳腺癌中胚系 BRCA1/2 突变与 TP53 基因突变和同源重组修复相关基因的关系。
Hum Genomics. 2023 Jan 6;17(1):2. doi: 10.1186/s40246-022-00447-3.
9
Decoding cancer and herbal renaissance.解读癌症与草药复兴。
Longhua Chin Med. 2022 Sep;5. doi: 10.21037/lcm-22-12. Epub 2022 Sep 30.
10
Heterozygotic Brca1 mutation initiates mouse genome instability at embryonic stage.杂合性Brca1突变在胚胎期引发小鼠基因组不稳定。
Oncogenesis. 2022 Jul 22;11(1):41. doi: 10.1038/s41389-022-00417-3.